ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments

por Hatakeyama, Shinji, Summermatter, Serge, Jourdain, Marie, Melly, Stefan, Minetti, Giulia C., Lach-Trifilieff, Estelle
Publicado 2016

A High-Throughput Screening Identifies MICU1 Targeting Compounds

por Di Marco, Giulia, Vallese, Francesca, Jourde, Benjamin, Bergsdorf, Christian, Sturlese, Mattia, De Mario, Agnese, Techer-Etienne, Valerie, Haasen, Dorothea, Oberhauser, Berndt, Schleeger, Simone, Minetti, Giulia, Moro, Stefano, Rizzuto, Rosario, De Stefani, Diego, Fornaro, Mara, Mammucari, Cristina
Publicado 2020

Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

por Morvan, Frederic, Rondeau, Jean-Michel, Zou, Chao, Minetti, Giulia, Scheufler, Clemens, Scharenberg, Meike, Jacobi, Carsten, Brebbia, Pascale, Ritter, Veronique, Toussaint, Gauthier, Koelbing, Claudia, Leber, Xavier, Schilb, Alain, Witte, Florian, Lehmann, Sylvie, Koch, Elke, Geisse, Sabine, Glass, David J., Lach-Trifilieff, Estelle
Publicado 2017